A Trial of HRS-6768 in Patients With Advanced Solid Tumors

NCT06925581 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: HRS-6768

Sponsor

Jiangsu HengRui Medicine Co., Ltd.